Abstract. The Akt pathway is considered a pivotal player in regulating cell survival, growth, migration and angiogenesis. Disruption of normal Akt/PKB/PTEN signaling frequently occurs in numerous types of human cancers. Therefore, this signaling pathway is regarded as an important target for effective cancer therapeutic strategies. In the present study, methanol extracts from Scutellaria barbata (S. barbata) were determined to be Akt/protein kinase B inhibitory, after screening a panel of 40 traditional Chinese herbs with the Fast Activated Cellbased ELISA (FACE) assay. S. barbata extracts were found to suppress the phosphorylation levels of Akt. This inhibition was Akt kinase-specific as it had no effect on PI3K, the upstream kinase of Akt, whereas the levels of phosphorylated Bad and FHKR, the two downstream targets of Akt, changed as the levels of Akt changed. S. barbata extracts also exhibited cytotoxicity against LoVo and human umbilical vein endothelial cells (HUVECs). Furthermore, this extract inhibited the process of in vitro angiogenesis of HUVECs on Matrigel. S. barbata may be a suitable alternative source with which to isolate small molecules for use as Akt kinase inhibitors.
Introduction
The serine/threonine kinase Akt/PKB, a downstream target of phosphatidylinositol 3-kinase (PI3K), has been found to play a key role in the regulation of cell survival, migration, proliferation, metabolism, tumor growth and angiogenesis (1) (2) (3) (4) (5) . Akt is a subfamily of the mammalian cAMP-dependent, cGMPdependent, protein kinase C (AGC) family of kinases. To date, there are 3 Akt family members identified in mammals, designated as Akt1/PKBα, Akt2/PKBβ and Akt3/PKBλ (6, 7) . Disturbed activation of the PI3K-Akt pathway has been associated with the development of diseases, such as cancer, diabetes mellitus and autoimmunity (8) (9) (10) (11) (12) (13) . Akt is targeted by genomic aberrations including mutations, amplifications and rearrangements more frequently than any other pathway in human cancer, with the possible exception of the p53 and retinoblastoma (Rb) pathways (14) . The activation of Akt has been reported in many types of human cancers, including breast, prostate, gastric, lung, ovary, pancreas and thyroid carcinomas, as well as in glioblastoma and various hematological malignancies (15) . As the PI3K pathway is activated in cancer, this makes it an ideal target for therapy as it is easier to inhibit activation events than to replace lost tumor-suppressor function. A number of inhibitors of proteins involved in the PI3K/Akt signaling pathway have been under development, and some agents have now entered clinical trials or have been approved for clinical practice, including inhibitors that directly inhibit the PI3K/Akt/mTOR pathway and those that do so indirectly, by suppressing the upstream regulators of PI3K/Akt, such as membrane growth factor receptors (16) .
In the present study, a Fast Activated Cell-based ELISA (FACE) assay was applied to screen Akt kinase inhibitors against a panel of traditional Chinese herbs believed to have anticancer properties. Scutellaria barbata (S. barbata) was identified as the most suitable among them to suppress the phosphorylation level of Akt kinase in LoVo cells. S. barbata also disrupted the process of in vitro angiogenesis by human umbilical vein endothelial cells on Matrigel.
Materials and methods
Herbal materials. All herbal powders were purchased from a local Chinese medicine distributor (Atlanta, GA, USA) (Table I) . LoVo cells were obtained from ATCC (Manassas, VA) and human umbilical vein endothelial cells were acquired from Lonza. LY294002 was from Calbiochem. The FACE kit was from Active Motif (Carlsbad, CA, USA) and CellTiter-Glo Luminescent Cell Viability Assay kit was from Promega (Madison, WI, USA). Briefly, cells were fixed by replacing the growth medium with 100 µl of 4% formaldehyde in PBS and incubated at room temperature for 20 min. After washing the cells 3 times with 200 µl wash buffer (5 min x 3), 100 µl quenching buffer was added to each well and incubation was carried out for 20 min at room temperature. Cells were washed 2 times (5 min x 2) with 200 µl wash buffer and then 100 µl antibody blocking buffer was added to each well and incubation was carried out for 1 h at room temperature. After removing the antibody blocking buffer and washing cells 2 times with 200 µl wash buffer, 40 µl of diluted primary antibody (or antibody dilution buffer for negative control wells) was added to each well and the plate was sealed with sealing tape. The plate was then covered with a lid and incubated overnight at 4˚C. After removing the primary antibody and washing cells 3 times with 200 µl wash buffer, 100 µl diluted secondary antibody was added to each well and the plate was covered with sealing tape and incubated 1 h at room temperature. After removing the secondary antibody, cells were washed 3 times with 200 µl wash buffer and then 2 times with 200 µl 1X PBS. Developing solution (100 µl) was added to each well and incubation was carried out for 2-20 min at room temperature. Absorbance was measured on a spectrophotometer within 5 min at 450 nm with an optional reference wavelength of 655 nm. After reading the chemiluminescence, cells were stained with crystal violet and read at OD595. These numbers were used to normalize the cell numbers among different wells. The change in phosphorylation status was calculated by dividing the chemiluminscence detected using the phospho Akt-specific antibody with that of the total Akt-specific antibody.
Antitumor and anti-angiogenic activities of

Western blot analysis of the inhibition of Akt phosphorylation in LoVo cells by S. barbata extracts.
For the Western blot analysis, 6x10 6 LoVo cells were plated into a T-25 flask and cultured overnight. Cells in different flasks were then treated with or without S. barbata herbal extracts for 3 h. Cells were washed with PBS and lysed with 400 µl lysis buffer as described (41) . Samples were resolved by 10% SDS-PAGE under reducing conditions and transferred onto nitrocellulose . After an extensive wash, bands were detected by enhanced chemiluminescence (ECL) (Pierce). Subsequently, the same membrane was stripped and reprobed for total protein loading using an anti-Akt antibody. For the Western blot analysis of PI3K, FKHR and Bad, the procedures were essentially the same as for Akt.
Cytotoxicity of S. barbata extracts on LoVo cells. LoVo cells
were plated in a 96 well opaque-walled tissue culture plate at 70,000 cells/well in 100 µl culture medium. Following overnight culture, cells were treated with S. barbata extracts in DMSO at different concentrations of 0.6, 1.25, 2.5, 5 and 10 µg/ml for 3 h. Cells treated with DMSO (2 µl) were used as the negative control. After 3 h, cell viability was measured by the CellTiter-Glo Luminescent Cell Viability Assay kit from Promega, according to the manufacturer's instructions. Cytotoxicity was calculated as the percent decrease in ATP levels of cells treated with S. barbata extracts as compared with that of cells treated with DMSO.
In vitro anti-angiogenesis assay. HUVECs (42,000 viable cells/ cm
2 ) were seeded on a 24-well polystyrene plate coated with Matrigel (BD Biosciences) (50 µl/cm 2 ) in HUVEC medium supplemented with or without S. barbata herbal extract at a concentration of 5 µg/ml and incubated overnight at 37˚C and 5% CO 2 .
Results
FACE screening results.
Data from the FACE screening showed that 6 herbal extracts had values similar to LY294002 (Fig. 1) . A second round of FACE screening was conducted for those 6 extracts with a series of different concentrations. The results showed that S. barbata extracts were the most effective at much lower concentrations, and thus was chosen for further analysis.
Inhibition of Akt phosphorylation in LoVo cells by S. barbata extracts.
Western blot analysis showed that the level of phosphorylated Akt decreased with increasing concentrations of S. barbata extracts in the culture medium ( Fig. 2A) . At 10 µg/ ml, S. barbata achieved approximately the same level of Akt phosphorylation inhibition as that of LY294002. There was no change in the phosphorylation level of PI3K kinase after treatment with the S. barbata extracts (Fig. 2C ). The phosphorylation level of Bad correlated with the level of Akt. In contrast, the level of phosphorylated FKHR increased with a decreasing level of phosphorylation of Akt (Fig. 2B) . Fig. 3 showed the percent decrease in ATP levels of cells treated with S. barbata extracts as compared with cells treated with DMSO. Cell ATP levels decreased as S. barbata extract levels in the culture increased, and at 10 µg/ml, the cell ATP level was barely less than 25% of that in the DMSO-treated cells.
Cytotoxicity of S. barbata extracts against LoVo cells.
In vitro anti-angiogenesis assay. As shown in Fig. 4 , the in vitro tube formation process of HUVECs on Matrigel was completely inhibited when the S. barbata extract was added to the culture at a concentration of 5 µg/ml. 
Discussion
The phosphatidylinostitol-3-kinase (PI3K)/PTEN/Akt pathway is involved in a number of human cancers, and Akt is a key player in cancer cell proliferation and survival (15, (17) (18) (19) (20) (21) (22) . Great effort has been made in designing small-molecule Akt inhibitors, particularly following the availability of the X-ray structure of the active form of Akt. Current Akt inhibitors mainly bind to the ATP-binding site, allosteric sites and the PH domain. Moreover, studies exist involving Akt inhibitors composed of pseudo-substrates and antisense oligonucleotides as well as inhibitors with unknown action mechanisms (22) .
S. barbata has been used in traditional Chinese medicine as an anti-inflammatory and antitumor agent, and also as a diuretic. Extracts of S. barbata have been shown to exhibit in vivo growth inhibitory effects on a number of cancer types (23) (24) (25) (26) (27) . This herbal agent is known to contain a large number of alkaloids and flavones, frequently found as glucoside and other constituents, including phenethyl alcohols, sterols, essential oils and amino acids. It was found that a 30% ethanol extract of S. barbata induced apoptosis in the lung cancer A549 cell line (28) , the methylene chloride fraction of S. barbata induced apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway (29) , and the chloroform fraction exhibited strong cytotoxicity on the cancer cell line Bel-7402 with a lower cytotoxic effect on a normal liver cell line (30) . It has been suggested that the extracts of S. barbata exert their antitumor and antiproliferative effects through different mechanisms. S. barbata was also found to inhibit the proliferation of myometrial and leiomyomal smooth muscle cells through the induction of α-SMA, calponin h1 and p27 (31) . It also enhanced apoptosis via the suppression of ERK-mediated autophagy in estrogen receptor-negative human breast adenocarcinoma MDA-MB-231 cells through photo-activated pheophorbide-a (32), and in mouse hepatoma H22 cells through the release of cytochrome C and activation of caspase-3 (33). Significant apoptosis induction has been observed in TRAMP-C1 and LNCaP cells treated with S. barbata (1 mg/ml) (34) . An aqueous extract from S. barbata, BZL101, induced the production of reactive oxygen species in tumor cells, and therefore caused extensive oxidative DNA damage leading to necrotic death (35) .
In the present study, a FACE method was used to screen an Akt inhibitor against a panel of 40 traditional Chinese herbs. Among 6 herbal extracts with anti-Akt phosphorylation activity based on a preliminary screening, S. barbata was chosen for further analysis. Western blot analysis and the cell viability assay suggest that the antitumor and antiproliferative 
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properties of the S. barbata extracts may be attributed to the inhibition of Akt kinase phosphorylation. This Akt inhibition was found to be specific as PI3K kinase, the upstream kinase of Akt, was not inhibited, whereas the levels of phosphorylated Bad and FHKR, the two downstream targets of Akt, changed as the level of Akt changed. It is known that certain synthetic small-molecule Akt inhibitors are associated with unexpected toxicities, such as increased blood glucose and insulin levels, hyperglycemia, and acute systemic hypotension (36) (37) (38) . Thus, S. barbata may be a suitable alternative source to isolate small molecules for use as Akt kinase inhibitors, as this herb has been safely used for a long time.
The expression of PI3K and Akt in cancer cells is required for tumor angiogenesis, and down-regulation of PI3K or Akt by their siRNA constructs in human ovarian cancer cells greatly decreases tumor growth and angiogenesis (39) . Treatment with LY294002 was found to decrease glioma tumor growth and the tumor-induced angiogenic response (40) . It is evident from our study that S. barbata extracts completely blocked the process of HUVEC angiogenesis in vitro on Matrigel at a concentration of 5 µg/ml. Furthermore, S. barbata extracts also inhibited Akt phosphorylation and cell proliferation in HUVECs.
